European Union (EU)
pharmaceutical legislation known as the Clinical Trials Regulation entered into
application on 31 January 2022. It aims to ensure the EU offers an
attractive and favourable environment for carrying out clinical research
on a large scale, with high standards of public transparency and safety
for clinical trial participants.
Comments
Post a Comment